00:04:43 Vickie Danaher They also still help lower post-meal glucose, but their appetite-regulating effects are a big reason why they lead to clinically meaningful weight loss
Esser AK, Ross MH, Fontana F, Su X, Gabay A, Fox GC, et al
In contrast, semaglutide GLP-1 is marketed under the brand name Wegovy when it is specifically intended for weight management
Clinical trials (such as SUSTAIN-6) have shown cardiovascular benefits in people with type 2 diabetes taking semaglutide, though it does not have a specific UK indication for cardiovascular risk reduction
Colbert said, "Mounjaro or Tirzepatide turns off two key appetite hormones, and then the new one's coming out, the Retatrutide, which comes out probably next year, turns off three." In addition, Colbert described how patients experience slower digestion
The post-operative period itself often involves reduced caloric intake from anesthesia recovery, post-op nausea, and altered routines, which may partially offset the appetite rebound